A Study of the Safety and Effectiveness of Eltrombopag in Combination With Immunosuppressive Therapy (IST) in Korean Pediatric Patients With Treatment Naïve Severe Aplastic Anemia
Clinical trial NCT07415083 · COMPLETED
Trial details
- NCT number
- NCT07415083
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-06-21
- Primary completion
- 2025-02-25
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.